HIGH-VOLUME · HOSP-HEAVY

budesonide Side Effects

budesonide (also sold as Pulmicort, Entocort) is HIGH-VOLUME in this FAERS book #133 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 31.7% mention hospitalization (17,576 reports).

Data updated 2026-05-15

55,389
FAERS reports

FAERS voluntary reports, 2002 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.

budesonide: 31.7% mention hospitalization (17,576 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #133 of 524 by FAERS report count.

High-report extract for budesonide (Pulmicort): 55,389 FAERS rows (2002-2025). Top named reactions: DYSPNOEA, ASTHMA, FATIGUE. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.

Counts from the openFDA FAERS extract (2002–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.

DYSPNOEA leads 6,364 of 55,389 reports

DYSPNOEA
6,364
ASTHMA
4,695
FATIGUE
3,354
COUGH
3,164
HEADACHE
2,978
CONDITION AGGRAVATED
2,696
DIARRHOEA
2,696
NAUSEA
2,621
PNEUMONIA
2,556
WHEEZING
2,399
MALAISE
2,194
PYREXIA
2,117
PAIN
2,104
WEIGHT DECREASED
1,961
ARTHRALGIA
1,783
DIZZINESS
1,755
ABDOMINAL PAIN
1,666

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 29,975 (59%)
Male 20,480 (41%)
Unknown 107

Age peak 45-64 (11,789 reports)

0-17 3,932 (11%)
18-44 8,050 (22%)
45-64 11,789 (32%)
65-74 7,253 (20%)
75+ 5,925 (16%)

FAERS filings rising toward 2025

2002 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (3,535 reports, 6.4%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 1,218
PNEUMONIA 374
DYSPNOEA 304
RENAL FAILURE 231
RESPIRATORY FAILURE 227
PULMONARY EMBOLISM 217
CONDITION AGGRAVATED 215
MULTIPLE ORGAN DYSFUNCTION SYNDROME 210
SEPSIS 206
ACUTE KIDNEY INJURY 188
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 187
DIARRHOEA 187
LUNG DISORDER 179
PYREXIA 154
ASTHMA 152
ASTHENIA 150
ANAEMIA 146

Reactions in Hospitalization Reports

Hospitalization is HEAVY (17,576, 31.7% of the book). Top reactions in those rows:

Reaction Reports
DYSPNOEA 2,848
ASTHMA 2,176
PNEUMONIA 1,839
WHEEZING 1,381
PYREXIA 1,248
CONDITION AGGRAVATED 1,233
HEADACHE 1,185
NAUSEA 1,180
COUGH 1,159
THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1,119
FATIGUE 1,111
PAIN 1,111
DIARRHOEA 1,059
ABDOMINAL PAIN 964
MALAISE 958
WEIGHT DECREASED 912
VOMITING 904
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 834
How to read budesonide FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)

FAERS holds 55,389 voluntary reports linked to budesonide (Pulmicort, Entocort), 2002-2025. Death is listed on 3,535 (6.4%). Hospitalization appears on 17,576 (31.7%). Top co-reported indication: Product Used For Unknown Indication.

CASELOAD books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.

Read with budesonide

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.